French healthtech startup MyC raises €10M to digitalise medical operations at complex worksites

In many high-risk sectors, such as energy, industry, maritime, defense or specialised medical services, employee health management still largely relies on fragmented tools that are poorly suited to multi-site and international environments.

MyC addresses these challenges by providing an operational response tailored to such contexts. Its platform covers both occupational health and first-line medical care, while ensuring a high level of security and compliance with international standards.

Read Also - TechBBQ receives €2M grant to elevate Denmark’s global startup profile

It improves operational efficiency through process automation, including pharmaceutical management, medical records management with specialist consultations, and regulatory reporting. Designed to operate in complex conditions, including limited connectivity, the platform enables rapid, large-scale deployments.

Founded in 2020 by Dr Laurent Bonnardot, an ENT physician and emergency doctor with extensive experience in isolated and complex environments, and Benjamin Crevant, an entrepreneur from the industrial sector, MyC develops a cloud-based platform that centralises and secures employees’ medical data.

According to Dr Laurent Bonnardot, co-founder of MyC:

“For more than twenty years, from industrial sites to offshore platforms, I managed employee health using fragmented systems. Even the world’s largest organisations lacked truly fit-for-purpose tools.

MyC was born out of this frustration: providing international companies with a single platform capable of covering all their needs, from on-site medical follow-up to multi-country regulatory compliance, where traditional solutions fall short."

MyC addresses a structural challenge for many organisations: gaining access to a reliable, secure and actionable view of employee health in complex, highly regulated environments,” says Valérie Gombart, co-founder and Managing Director of Hi inov.

“The platform combines strong domain expertise rooted in medical field experience with a robust SaaS technology designed for international deployment. This investment fully aligns with our strategy to support European B2B companies delivering tangible operational value to essential industries.”

With this funding, MyC aims to improve its product and expand its sales and marketing teams to reach more international enterprise customers.